Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Discover why allocating more bonds as you age can stabilize withdrawals and protect capital. A brief primer on safer retirement strategies.
27,889 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
A major hedge fund exit grabbed headlines as a fund controlled by William Oberndorf liquidated a sizable monday.com s...
Stride stock has fallen significantly over the last year. This article digs into the reasons behind the decline and e...
A Dream Finders insider sale grabbed attention after the stock dropped nearly 30%. This guide breaks down what know a...
Pfizer may be sitting on a hidden GLP-1 opportunity. This article breaks down why the company could prove to be an un...
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
If you’re searching for a medical-device stock you can own for decades, Medtronic stands out. This article breaks dow...
A patient fund manager shows strong conviction, piling another $10 million into Turning Point Brands. The move highli...
ASML stock rose in May as demand for EUV technology and a healthier semiconductor cycle supported the rally. This gui...
Nio delivered a staggering 129% jump in EV sales, yet its stock slid in May. This analysis breaks down the drivers be...
SoFi Technologies posted record fourth-quarter results and added a million members, yet the stock sits around $18. Th...
Builders are flocking to fast-growing regions. This guide explains which markets are rising, why lenders support them...